Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening.
- 1 January 2002
- journal article
- Published by Microbiology Research Foundation in The Journal of General and Applied Microbiology
- Vol. 48 (6), 329-334
- https://doi.org/10.2323/jgam.48.329
Abstract
An industrially applied rifamycin B-producing strain, Amycolatopsis mediterranei XC 1-02, was used for further screening. A special mutation and screening procedure was adopted to select a strain, which can alleviate the inhibition caused by both aromatic amino acid and p-hydroxybenzoic acid in the pathway of rifamycin B biosynthesis as well as enhance the production of propionate, one of the precursors of rifamycin B biosynthesis. By the above methods, a strain A. mediterranei XC 9-25 was obtained, and its rifamycin B productivity in shaking flask reaches 10 g/L, which is 2.38 times higher than that of the ancestral strain XC 1-02. The productivity of rifamycin B fed-batch fermentation in 60000 L fermentor with A. mediterranei XC 9-25 reached 19.11 g/L.Keywords
This publication has 9 references indexed in Scilit:
- RifamycinsPublished by Informa UK Limited ,1997
- Tuberculosis in the AIDS eraClinical Microbiology Reviews, 1995
- Regulation of the biosynthetic pathway of aromatic amino acids in Nocardia mediterraneiBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- 3-Amino-5-hydroxybenzoic acid as a key intermediate in ansamycin and maytansinoid biosynthesisJournal of the Chemical Society, Chemical Communications, 1980
- A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-producton.The Journal of Antibiotics, 1978
- A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production.The Journal of Antibiotics, 1978
- Chemistry of the Ansamycin AntibioticsPublished by Springer Science and Business Media LLC ,1976
- Ansamycin biogenesis: Incorporation of [1‐13C]glucose and [1‐13C]glycerate into the chromophore of rifamycin SFEBS Letters, 1974
- Über die Konstitution und die Konfiguration der Rifamycine B, O, S und SVHelvetica Chimica Acta, 1973